CLIA Kit for Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3)

A20; OTUD7C; TNFA1P2; OTU domain-containing protein 7C; Putative DNA-binding protein A20; Zinc finger protein A20

  • CLIA Kit for Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) Packages (Simulation)
  • CLIA Kit for Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) Packages (Simulation)
  • CLIA Kit for Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) Results demonstration
  • SCC796Hu.jpg Typical Standard Curve
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specificity of the CLIA Kit for Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3)

This assay has high sensitivity and excellent specificity for detection of Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3).
No significant cross-reactivity or interference between Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) and analogues was observed.

Recovery of the CLIA Kit for Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3)

Matrices listed below were spiked with certain level of recombinant Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) and the recovery rates were calculated by comparing the measured value to the expected amount of Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 99-105 102
EDTA plasma(n=5) 86-101 93
heparin plasma(n=5) 85-92 88

Precision of the CLIA Kit for Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3)

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity of the CLIA Kit for Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3)

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 78-92% 84-101% 80-88% 83-91%
EDTA plasma(n=5) 97-105% 80-97% 84-96% 84-91%
heparin plasma(n=5) 94-104% 90-104% 95-103% 96-105%

Stability of the CLIA Kit for Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3)

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary of the CLIA Kit for Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3)

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 100µL Substrate Solution. Incubate 10 minutes at 37°C;
8. Read RLU value immediately.

Test principle of the CLIA Kit for Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3)

The microplate provided in this kit has been pre-coated with an antibody specific to Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3). Standards or samples are then added to the appropriate microplate wells with a biotin-conjugated antibody specific to Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) level in the sample or standard.;

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
RPC796Hu01 Recombinant Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) Positive Control; Immunogen; SDS-PAGE; WB.
PAC796Hu01 Polyclonal Antibody to Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) WB; IHC; ICC; IP.
MAC796Hu21 Monoclonal Antibody to Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) WB; IHC; ICC; IP.
SEC796Hu ELISA Kit for Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) Enzyme-linked immunosorbent assay for Antigen Detection.
SCC796Hu CLIA Kit for Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) Chemiluminescent immunoassay for Antigen Detection.
LMC796Hu Multiplex Assay Kit for Tumor Necrosis Factor Alpha Induced Protein 3 (TNFaIP3) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
GUESTBOOK